Tecfidera, a medication commonly prescribed for multiple sclerosis (MS), can cause weight loss in some patients, although this is not its primary effect or a guaranteed outcome. Weight changes during Tecfidera treatment are generally linked to its side effects rather…
Tecfidera (dimethyl fumarate) does affect the immune system by modulating its activity, but it does not simply “weaken” it in a straightforward way. Instead, Tecfidera works by altering immune responses to reduce the harmful inflammation associated with multiple sclerosis (MS),…
Tecfidera is a medication primarily used to treat relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS (RRMS). Its benefits stem from its ability to modify the disease course by reducing the frequency of relapses, slowing the progression of disability,…
Tecfidera, a medication commonly prescribed for multiple sclerosis (MS), has been associated with potential effects on the liver, including the possibility of liver damage. While it is effective in managing MS symptoms, it can cause an increase in liver enzymes,…
Tecfidera, a medication commonly prescribed for relapsing forms of multiple sclerosis (MS), is known to cause flushing as one of its side effects. Flushing refers to a sudden reddening of the skin, often accompanied by a feeling of warmth, typically…
Tecfidera, a medication commonly prescribed to manage multiple sclerosis (MS), can cause a variety of side effects that range from mild to more serious. Understanding these side effects is important for anyone taking the drug or considering it as a…
Ocrevus and Rituxan are both monoclonal antibody therapies used to treat multiple sclerosis (MS), but they have differences in their development, approval, dosing schedules, safety profiles, and clinical use that distinguish them from each other. Both Ocrevus (generic name ocrelizumab)…
Ocrevus (ocrelizumab) is a medication used primarily to treat multiple sclerosis (MS), including both relapsing forms and primary progressive MS. While it has been effective in managing disease activity, understanding the long-term risks associated with Ocrevus is crucial for patients…
Drinking alcohol while on Ocrevus (ocrelizumab) is generally not contraindicated, but it requires careful consideration due to potential effects on your body and the medication’s impact. Ocrevus is a medication used to treat multiple sclerosis (MS), including relapsing forms and…
Ocrevus (ocrelizumab) is a medication used to treat multiple sclerosis (MS), including relapsing forms and primary progressive MS. It is administered by intravenous infusion every six months, typically in a healthcare setting under medical supervision. One of the common side…